Prognostic value and clinical usefulness of PIANO score in patients undergoing primary percutaneous coronary intervention

医学 传统PCI 经皮冠状动脉介入治疗 危险系数 内科学 临床终点 心肌梗塞 心脏病学 人口 置信区间 外科 临床试验 环境卫生
作者
Chunfeng Dai,Zheng Yang,Muyin Liu,You Zhou,Danbo Lu,Shufu Chang,Chenguang Li,Hao Lu,Zhangwei Chen,Juying Qian,Junbo Ge
出处
期刊:International Journal of Cardiology [Elsevier]
卷期号:390: 131258-131258 被引量:2
标识
DOI:10.1016/j.ijcard.2023.131258
摘要

Background In our previous study, the PIANO score was constructed to predict the occurrence of no-reflow phenomenon in patients undergoing primary percutaneous coronary intervention (PCI). In the current analysis, we sought to evaluate the prognostic value and clinical usefulness of the PIANO score in this population. Methods Patients with acute myocardial infarction (AMI) undergoing primary PCI were consecutively enrolled and followed up in this register. The endpoint of interest was all-cause mortality at 2 years after the procedure. The clinical benefits of thrombus aspiration (TA) during primary PCI in certain subgroups were also evaluated as exploratory analyses. Results A total of 2100 patients were identified, and 54.3% had high (≥8) PIANO score. After 2-year follow-up, patients with high PIANO score had higher risk of all-cause mortality after adjustment for propensity score (6.7% vs. 3.1%, adjusted hazard ratio = 2.11 [1.21–3.68], p = 0.008), especially in the first month (adjusted hazard ratio = 2.33 [1.17–4.65], p = 0.017). Restricted cubic spline analysis indicated the linear association between the PIANO score and 2-year all-cause mortality (nonlinear p = 0.556). Further analysis demonstrated that TA did not reduce all-cause mortality in the overall patients, as well as in those with visible thrombus, high thrombus burden, or occlusive lesions. However, the PIANO score defined "high-risk" (PIANO score ≥ 8) patients could benefit from it. Conclusions The PIANO score had potential prognostic value in patients with AMI undergoing primary PCI. It might also be helpful for identifying patients who would benefit from TA. These observations require further confirmation in future studies.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
闫132完成签到,获得积分10
1秒前
顺利如冰完成签到,获得积分10
3秒前
水文小白完成签到,获得积分10
3秒前
6秒前
MRIFFF完成签到,获得积分10
8秒前
困困困完成签到 ,获得积分10
9秒前
guojingjing完成签到 ,获得积分10
18秒前
细心的语蓉完成签到,获得积分10
23秒前
mrwang完成签到 ,获得积分10
25秒前
nt1119完成签到 ,获得积分10
26秒前
Susie完成签到 ,获得积分10
32秒前
40秒前
吕健完成签到,获得积分10
41秒前
小古发布了新的文献求助10
44秒前
Summer_Xia完成签到 ,获得积分10
45秒前
芒果布丁完成签到 ,获得积分10
46秒前
巫巫巫巫巫完成签到 ,获得积分10
48秒前
ROOKIE完成签到,获得积分10
49秒前
一枝完成签到 ,获得积分10
53秒前
dhdhg完成签到 ,获得积分10
59秒前
taipingyang完成签到,获得积分10
1分钟前
博士完成签到 ,获得积分10
1分钟前
wenbinvan完成签到,获得积分0
1分钟前
牛人完成签到,获得积分10
1分钟前
锦上添花完成签到 ,获得积分10
1分钟前
1分钟前
橙子完成签到,获得积分10
1分钟前
平常雨泽完成签到 ,获得积分10
1分钟前
rita_sun1969完成签到,获得积分10
1分钟前
wo_qq111完成签到 ,获得积分10
1分钟前
王春琰完成签到 ,获得积分10
1分钟前
汪汪淬冰冰完成签到,获得积分10
1分钟前
SimonShaw完成签到,获得积分10
1分钟前
梦断奈何完成签到 ,获得积分10
1分钟前
JJ完成签到 ,获得积分10
1分钟前
SDNUDRUG完成签到,获得积分10
1分钟前
科研小南瓜完成签到 ,获得积分10
2分钟前
握瑾怀瑜完成签到 ,获得积分0
2分钟前
CDabin完成签到,获得积分10
2分钟前
温馨完成签到 ,获得积分10
2分钟前
高分求助中
Sustainability in ’Tides Chemistry 2000
Studien zur Ideengeschichte der Gesetzgebung 1000
The ACS Guide to Scholarly Communication 1000
TM 5-855-1(Fundamentals of protective design for conventional weapons) 1000
Handbook of the Mammals of the World – Volume 3: Primates 805
Ethnicities: Media, Health, and Coping 800
Gerard de Lairesse : an artist between stage and studio 500
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3072753
求助须知:如何正确求助?哪些是违规求助? 2726386
关于积分的说明 7493908
捐赠科研通 2374311
什么是DOI,文献DOI怎么找? 1258960
科研通“疑难数据库(出版商)”最低求助积分说明 610434
版权声明 596997